SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-272057
Filing Date
2020-10-19
Accepted
2020-10-19 16:22:02
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d115572ds3.htm S-3 328476
2 EX-4.3 d115572dex43.htm EX-4.3 317583
3 EX-4.5 d115572dex45.htm EX-4.5 116055
4 EX-4.6 d115572dex46.htm EX-4.6 121044
5 EX-4.7 d115572dex47.htm EX-4.7 110934
6 EX-5.1 d115572dex51.htm EX-5.1 28114
7 EX-23.1 d115572dex231.htm EX-23.1 1526
8 GRAPHIC g115572cooley_logo.jpg GRAPHIC 3782
9 GRAPHIC g115572g34s03.jpg GRAPHIC 30739
  Complete submission text file 0001193125-20-272057.txt   1067759
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249544 | Film No.: 201246412
SIC: 2836 Biological Products, (No Diagnostic Substances)